Workflow
微泡片
icon
Search documents
十年深耕,自然共生:Swisse斯维诗的中国市场“进击之路”
3 6 Ke· 2025-12-11 10:32
入华十年,Swisse斯维诗想定义健康消费新范式 过去十年,堪称是中国新消费赛道高速发展的十年。作为其中的代表性领域,中国营养健康市场也经历 了从野蛮生长到监管趋于规范,消费者信任缺失到开始追求品质的变化。 大浪淘沙的阶段,入局者数不胜数,都渴望在这片潜力巨大的蓝海市场中抢占先机。如今回看产业的发 展历程,一个颇为有趣的现象是,在消费者心中建立起深度联结和信任的,似乎并不只是一些长期深耕 本土的传统品牌,还有不少年轻的"外来者"。 成长于澳洲的Swisse就是其中的一个。 这家有着"外来基因"的营养品品牌,在十年间一路突破了地域认知壁垒、消费习惯差异等多重挑战。据 健合集团相关信息,如今,斯维诗在国内维生素、草本及矿物补充剂(VHMS)的市场排名已位居第 一;此外,2025年前三季度,集团的成人营养与护理品(ANC)板块收入达到52.4亿元。其中,斯维诗 中国市场业绩同比增长15.7%,贡献了近七成的销售额。 12月8日,Swisse在广州开展了主题为"聚力共赢 稳健增长"的十周年合作伙伴大会。大会上,斯维诗表 示将继续通过"核心专业品类深化"与"新兴赛道拓展"双轮驱动,更全面、精准地满足消费者日益多元的 健 ...
十年深耕,自然共生:Swisse斯维诗的中国市场“进击之路”
36氪未来消费· 2025-12-11 09:49
过去十年,堪称是中国新消费赛道高速发展的十年。作为其中的代表性领域,中国营养健康市场也经历了从野蛮生长到监管趋于规范,消费者信任缺失到开 始追求品质的变化。 大浪淘沙的阶段,入局者数不胜数,都渴望在这片潜力巨大的蓝海市场中抢占先机。如今 回看产业 的 发展 历程,一个颇为有趣的现象是,在消费者心中 建立起深度联结和信任的,似乎并不只是一些长期深耕本土的传统品牌,还有不少年轻的 "外来者"。 成长于澳洲的Swisse就是其中的一个。 这家有着 "外来基因"的营养品品牌,在十年间一路突破了地域认知壁垒、消费习惯差异等多重挑战。据健合集团相关信息, 如今, 斯维诗 在 国内维生 素、草本及矿物补充剂( VHMS) 的 市场 排名 已位居第一 ; 此外, 2025年前三季度,集团的成人营养与护理品(ANC)板块收入达到52.4亿元。 其 中,斯维诗中国市场业绩同比增长 15.7%,贡献了近七成的销售额。 12月8日,Swisse在广州开展了主题为"聚力共赢 稳健增长"的十周年合作伙伴大会。大会上,斯维诗表示将继续通过"核心专业品类深化"与"新兴赛道拓 展"双轮驱动,更全面、精准地满足消费者日益多元的健康需求,实现品牌 ...
汤臣倍健蒸发400亿:年轻人不怕老,不怕死,只怕穷?
凤凰网财经· 2025-08-20 12:27
Core Viewpoint - The health supplement market in China is experiencing significant challenges, as evidenced by the poor performance of leading companies like汤臣倍健, which has seen substantial declines in revenue and profit. However, the overall market is still growing, driven by younger consumers seeking health products, indicating a shift in consumer behavior and preferences [3][4][32]. Group 1: Company Performance -汤臣倍健 reported a revenue of 35.32 billion yuan in the first half of 2025, a year-on-year decline of 23.43%, with a net profit of 7.37 billion yuan, down 17.34% [3]. - For the entire year of 2024,汤臣倍健's revenue was 68.38 billion yuan, a decrease of 27.3%, and net profit fell by 62.62%, marking the largest decline since its listing [3][9]. - The company's market capitalization has dropped from a peak of 600 billion yuan to approximately 209 billion yuan, resulting in a loss of nearly 400 billion yuan in value [3][9]. Group 2: Market Trends - The health supplement industry is not in decline; rather, it is evolving, with younger consumers engaging in "punk health" practices, leading to increased spending on health products [5][14]. - Data from 2023 indicates a 255% increase in consumption of uric acid monitoring products among consumers born in the 1990s, with 30% of their spending on immune-boosting supplements [15]. - Brands targeting younger demographics, such as诺特兰德 and Swisse, are thriving by employing innovative marketing strategies and product offerings [16][19]. Group 3: Challenges and Strategies -汤臣倍健's traditional marketing and distribution strategies have become outdated, leading to a significant drop in sales across its product lines [10][11]. - The company has reduced its advertising and marketing expenses, which has further contributed to declining revenues and profits [11]. - Despite launching new products,汤臣倍健 has struggled to capture the younger market, missing out on the e-commerce boom and innovative marketing tactics that competitors have successfully utilized [12][17]. Group 4: Historical Context - The Chinese health supplement market has evolved over nearly 40 years, with discussions around "intelligence tax" continuing as long as consumers fear aging, death, and loss of beauty [21][32]. - The market saw significant growth in the 1990s, but regulatory changes led to a downturn, from which汤臣倍健 and other second-generation companies emerged to dominate the market [31][32]. - Recent data shows that the health supplement market generated sales of 604.1 billion yuan in the first half of 2025, reflecting a growth of 16.2%, with specific categories like sleep management products growing by 53.1% [32].
中国保健品行业2025:新消费驱动下的新趋势已现
Zhong Guo Shi Pin Wang· 2025-07-29 09:04
Core Insights - The health supplement market in China has become one of the largest globally, with significant growth potential remaining in the trillion-yuan market [1] - The online health supplement market is projected to exceed 120 billion by 2025, with an overall growth rate of 15% [2] - The consumer demographic is evolving, with a notable shift towards a "dumbbell-shaped" structure, where older adults and new middle-class consumers are driving demand [10] Market Overview - China's health supplement market is large and growing rapidly, with a projected market size of 399.8 billion in 2024, reflecting a 3% year-on-year growth [1] - By 2030, the market size is expected to surpass 1.5 trillion, maintaining a high compound annual growth rate [1] E-commerce Trends - E-commerce platforms are crucial channels for the health supplement industry, showing heightened growth trends [2] - Interest e-commerce is outpacing traditional shelf e-commerce, achieving over 20% annual growth [2] Product Development - The health supplement efficacy landscape is evolving, with traditional categories like bone health and immunity remaining strong, while new categories like moisture removal and emotional health are emerging [2][4] - Innovative product forms such as micro-bubbles and unique capsules are gaining traction, enhancing consumer experience beyond traditional forms [4] Pricing Dynamics - The average daily price of health supplements is around 10 yuan, with most efficacy products priced below 6 yuan, while categories like weight management and anti-aging command higher prices [6] - New products are achieving a premium price point, with an average daily price of 15.8 yuan compared to 8.7 yuan for older products, indicating a trend towards premiumization [8] New Product Strategy - 58% of existing brands are focusing on new product launches, averaging 4 new SKUs per brand annually, highlighting the importance of innovation in brand strategy [8] - New products account for 54% of the market by quantity, although they currently represent only 24% of sales, indicating growth potential [8] Consumer Demographics - The consumer base is shifting, with older adults (60+) contributing significantly to the market, transitioning from basic health to chronic disease prevention and management [10] - The new middle-class demographic (ages 25-45) is emerging as a core growth driver, shifting their focus from "curing" to "preventing" health issues [10]